The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

146 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
27
Scaffold Repurposing of Nucleosides (Adenosine Receptor Agonists): Enhanced Activity at the Human Dopamine and Norepinephrine Sodium Symporters.EBI
National Institute of Diabetes and Digestive and Kidney Diseases
30
Norbenzomorphan Scaffold: Chemical Tool for Modulating Sigma Receptor-Subtype Selectivity.EBI
The University of Texas At Austin
13
Novel sigma 1-antagonists with cis-(+)-normetazocine scaffold: synthesis, molecular modeling, and antinociceptive effect.EBI
University of Catania
19
Semi-Synthesis of Dimeric Cannabidiol Derivatives and Evaluation of their Affinity at Neurological Targets.EBI
University of South Carolina
5
Neuromodulating Alkaloids from Millipede Defensive Secretions.EBI
Virginia Tech
1
Development of Squaramides as Allosteric Modulators of the CB1 Receptor: Synthesis, Computational Studies, Biological Characterization, and Effects against Cocaine-Induced Behavioral Sensitization and Reinstatement in Rats.EBI
Research Triangle Institute
36
Synthesis and structure-affinity relationships of spirocyclic σ1 receptor ligands with tetrahydropyran scaffold.EBI
Universit£t M£nster
9
Enantiomerically Pure Indazole Bioisosteres of Ifenprodil and Ro 25-6981 as Negative Allosteric Modulators of NMDA Receptors with the GluN2B Subunit.EBI
Universitat Munster
17
Development of selective sigma-1 receptor ligands with antiallodynic activity: A focus on piperidine and piperazine scaffolds.EBI
University of Catania
47
Design, synthesis and biological evaluation of arylpropylamine derivatives as potential multi-target antidepressants.EBI
Nanjing Tech University
21
Seven-membered N-heterocycles as approved drugs and promising leads in medicinal chemistry as well as the metal-free domino access to their scaffolds.EBI
Adam Mickiewicz University
11
An orally bioavailable chemical probe of the Lysine Methyltransferases EZH2 and EZH1.EBI
UNC Eshelman School of Pharmacy
3
NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family.EBI
Johann Wolfgang Goethe University
42
Structure-affinity relationships of stereoisomers of norbenzomorphan-derived σ2R/TMEM97 modulators.EBI
The University of Texas at Austin
4
2-(Piperidin-3-yl)phthalimides reduce classical markers of cellular inflammation in LPS-challenged RAW 264.7 cells and also demonstrate potentially relevant sigma and serotonin receptor affinity in membrane preparations.EBI
National Institute on Aging
25
Synthesis of α3β4 Nicotinic Acetylcholine Receptor Modulators Derived from Aristoquinoline That Reduce Reinstatement of Cocaine-Seeking Behavior.EBI
University of Illinois Chicago
29
WLB-87848, a Selective σ1 Receptor Agonist, with an Unusually Positioned NH Group as Positive Ionizable Moiety and Showing Neuroprotective Activity.EBI
Welab Barcelona
2
2-Amino-5-arylethynyl-thiophen-3-yl-(phenyl)methanones as AEBI
National Institute of Diabetes and Digestive and Kidney Disease
28
Conformationally Restricted σEBI
Westf£Lische Wilhelms-Universit£T M£Nster
26
Indazole as a Phenol Bioisostere: Structure-Affinity Relationships of GluN2B-Selective NMDA Receptor Antagonists.EBI
University Munster
9
Dual EBI
Ghent University
23
Dual Piperidine-Based Histamine HEBI
Jagiellonian University Medical College
20
2,6-diazaspiro[3.4]octan-7-one derivatives as potent sigma-1 receptor antagonists that enhanced the antinociceptive effect of morphine and rescued morphine tolerance.EBI
Xuzhou Medical University
32
Targeting σEBI
The University of Texas At Austin
8
2-Phenylcyclopropylmethylamine (PCPMA) as a privileged scaffold for central nervous system drug design.EBI
Shanghaitech University
22
Alicyclic Ring Size Variation of 4-Phenyl-2-naphthoic Acid Derivatives as P2YEBI
National Institute of Diabetes and Digestive and Kidney Diseases
10
Novel S1R agonists counteracting NMDA excitotoxicity and oxidative stress: A step forward in the discovery of neuroprotective agents.EBI
University of Pavia
14
Discovery and computational studies of piperidine/piperazine-based compounds endowed with sigma receptor affinity.EBI
University of Messina
28
Discovery of AD258 as a Sigma Receptor Ligand with Potent Antiallodynic Activity.EBI
Universit£
12
What We Have Gained from Ibogaine: α3β4 Nicotinic Acetylcholine Receptor Inhibitors as Treatments for Substance Use Disorders.EBI
University of Illinois At Chicago
24
Pharmacology and Therapeutic Potential of Benzothiazole Analogues for Cocaine Use Disorder.EBI
High Point University
34
Discovery of WLB-89462, a New Drug-like and Highly Selective σEBI
Welab Barcelona
40
Design and Synthesis of Orally Active Quinolyl Pyrazinamides as Sigma 2 Receptor Ligands for the Treatment of Pancreatic Cancer.EBI
University of Michigan
45
Benzomorphan skeleton, a versatile scaffold for different targets: A comprehensive review.EBI
University of Catania
19
Development of Fluorescent 4-[4-(3EBI
University of Bari Aldo Moro
66
From dopamine 4 to sigma 1: Synthesis, SAR and biological characterization of a piperidine scaffold of σ1 modulators.EBI
University of Nebraska Medical Center
38
Structure-activity relationships of mixed σEBI
University of Catania
25
Synthesis and pharmacological characterization of multiply substituted 2H-chromene derivatives as P2YEBI
National Institute of Diabetes and Digestive and Kidney Diseases
1
Discovery and Optimization of Pyrrolopyrimidine Derivatives as Selective Disruptors of the Perinucleolar Compartment, a Marker of Tumor Progression toward Metastasis.EBI
University of Kansas
24
Discovery and Characterization of the First Nonpeptide Antagonists for the Relaxin-3/RXFP3 System.EBI
Research Triangle Institute
18
Preparation of novel analogs of 2-arylpiperidines and evaluation of their sigma receptor binding affinities.EBI
University of Texas At Austin
8
Synthesis of tropane-based σEBI
Westf£Lische Wilhelms-Universit£T M£Nster
20
Synthesis of 8-aminomorphans with high KOR affinity.EBI
Institut F£R Pharmazeutische Und Medizinische Chemie Der Universit£T M£Nster
2
The Alkaloids from EBI
University of Copenhagen
103
Discovery of Highly Potent Serotonin 5-HTEBI
Northwestern University
19
Dual Sigma-1 receptor antagonists and hydrogen sulfide-releasing compounds for pain treatment: Design, synthesis, and pharmacological evaluation.EBI
University of Catania
33
Synthesis and biological evaluation of conformationally restricted GluN2B ligands derived from eliprodil.EBI
Westf£Lische Wilhelms-Universit£T M£Nster
28
Discovery of Potent Cholinesterase Inhibition-Based Multi-Target-Directed Lead Compounds for Synaptoprotection in Alzheimer's Disease.EBI
Yeditepe University
14
Design, synthesis and biological evaluation of novel aminopropylcarboxamide derivatives as sigma ligands.EBI
University of Trieste
8
Research progress in biological activities of isochroman derivatives.EBI
Shaanxi University of Chinese Medicine
48
Benzylaminofentanyl derivates: Discovery of bifunctional μ opioid and σEBI
Jiangsu Ocean University
102
Positron Emission Tomography (PET) Imaging Tracers for Serotonin Receptors.EBI
Beijing Normal University
15
Development of tumor-targeting aza-vesamicol derivatives with high affinity for sigma receptors for cancer theranostics.EBI
Kanazawa University
13
Structure-Activity Studies of 1EBI
National Institute of Diabetes and Digestive and Kidney Diseases
38
Tricyclic Triazoles as σEBI
Esteve Pharmaceuticals
11
Spirocyclic Scaffolds in Medicinal Chemistry.EBI
Goethe University
18
Development of novel phenoxyalkylpiperidines as high-affinity Sigma-1 (σEBI
University of Bari Aldo Moro
45
Bridged Piperidine Analogues of a High Affinity Naphthalene-Based P2YEBI
National Institute of Diabetes and Digestive and Kidney Diseases
8
Fluoroalkylation of Dextromethorphan Improves CNS Exposure and Metabolic Stability.EBI
The University of Kansas
18
Selective AEBI
National Institute of Diabetes and Digestive and Kidney Diseases
8
Discovery of Investigational Drug CT1812, an Antagonist of the Sigma-2 Receptor Complex for Alzheimer's Disease.EBI
Cognition Therapeutics
27
New tetrahydroisoquinoline-based DEBI
City University of New York
15
Chemoenzymatic synthesis of 2,6-disubstituted tetrahydropyrans with high σEBI
Westf£Lische Wilhelms-Universit£T M£Nster
36
Structure-Activity Relationship of Heterocyclic P2YEBI
National Institute of Diabetes and Digestive and Kidney Diseases
35
Novel Sigma 1 Receptor Antagonists as Potential Therapeutics for Pain Management.EBI
The State University of New Jersey
19
Novel σEBI
Westf£Lische Wilhelms-Universit£T M£Nster
16
Synthesis, binding, and functional properties of tetrahydroisoquinolino-2-alkyl phenones as selective σEBI
Guangdong Medical University
25
Studies on the affinity of 6-[(EBI
Helmholtz-Zentrum Dresden-Rossendor
30
Synthesis and SAR Studies of 1EBI
University of Nebraska Medical Center
29
Small Molecules Selectively Targeting Sigma-1 Receptor for the Treatment of Neurological Diseases.EBI
Soochow University
4
Ifenprodil Stereoisomers: Synthesis, Absolute Configuration, and Correlation with Biological Activity.EBI
Westf£Lische Wilhelms-Universit£T M£Nster
42
Isoquinolinone derivatives as potent CNS multi-receptor DEBI
Jiangsu Ocean University
5
The Essential Medicinal Chemistry of Cannabidiol (CBD).EBI
University of Minnesota
17
Negative allosteric modulators of the GluN2B NMDA receptor with phenylethylamine structure embedded in ring-expanded and ring-contracted scaffolds.EBI
Institut F£R Pharmazeutische Und Medizinische Chemie Der Universit£T M£Nster
10
Sigma-1 and Sigma-2 Receptor Modulators as Potential Therapeutics for Alzheimer's Disease.EBI
Usona Institute
11
Fluorinated 2-Arylcyclopropan-1-amines - A new class of sigma receptor ligands.EBI
Universit£T M£Nster
8
Synthesis and EBI
Wilhelms-Universit�T M�Nster Corrensstr
13
Virtual Screening for Ligand Discovery at the σEBI
Harvard Medical School
20
Novel Dithiolane-Based Ligands Combining Sigma and NMDA Receptor Interactions as Potential Neuroprotective Agents.EBI
University of Modena and Reggio Emilia
20
Sigma Receptor Ligands Carrying a Nitric Oxide Donor Nitrate Moiety: Synthesis, In Silico, and Biological Evaluation.EBI
University of Catania
17
Synthesis, Cytotoxicity Evaluation, and Computational Insights of Novel 1,4-Diazepane-Based Sigma Ligands.EBI
University of Trieste
1
Isolation and Synthesis of Veranamine, an Antidepressant Lead from the Marine Sponge EBI
University of Mississippi
28
Thiophene bioisosteres of GluN2B selective NMDA receptor antagonists: Synthesis and pharmacological evaluation of [7]annuleno[b]thiophen-6-amines.EBI
Westf£Lische Wilhelms-Universit£T M£Nster
12
Benzimidazolone-based selective σEBI
University of Florida
15
Structure-Based Design of 3-(4-Aryl-1H-1,2,3-triazol-1-yl)-Biphenyl Derivatives as P2Y14 Receptor Antagonists.EBI
National Institute of Diabetes and Digestive and Kidney Diseases
50
Development of Novel Alkoxyisoxazoles as Sigma-1 Receptor Antagonists with Antinociceptive Efficacy.EBI
East China Normal University
4
Synthesis of spiro-2,6-dioxopiperazine and spiro-2,6-dioxopyrazine scaffolds using amino acids in a three-component reaction to generate potential Sigma-1 (σEBI
Memorial Sloan Kettering Cancer Center
112
Discovery, Optimization, and Characterization of ML417: A Novel and Highly Selective DEBI
National Institute of Neurological Disorders and Stroke
27
Truncated (N)-Methanocarba Nucleosides as Partial Agonists at Mouse and Human AEBI
Medical College of Wisconsin
20
Tetrahydro-3-benzazepines with fluorinated side chains as NMDA and σEBI
Institut F£R Pharmazeutische Und Medizinische Chemie Der Universit£T M£Nster
13
Synthesis, in vitro and in vivo characterization of new benzoxazole and benzothiazole-based sigma receptor ligands.EBI
University of Catania
32
Discovery of a novel class of potent and selective tetrahydroindazole-based sigma-1 receptor ligands.EBI
Northwestern University
23
SYA 013 analogs as moderately selective sigma-2 (σEBI
Florida A&M University
34
Synthesis and Structure-Affinity Relationships of Spirocyclic Benzopyrans with Exocyclic Amino Moiety.EBI
Universit£T M£Nster
21
Development of Novel Quinoxaline-Based κ-Opioid Receptor Agonists for the Treatment of Neuroinflammation.EBI
Universit£T M£Nster
37
Design and in Vivo Characterization of AEBI
Medical College of Wisconsin
12
Modification of the 4-phenylbutyl side chain of potent 3-benzazepine-based GluN2B receptor antagonists.EBI
Institut F£R Pharmazeutische Und Medizinische Chemie Der Universit£T M£Nster
10
Impact of hydroxy moieties at the benzo[7]annulene ring system of GluN2B ligands: Design, synthesis and biological evaluation.EBI
Institut F£R Pharmazeutische Und Medizinische Chemie Der Universit£T M£Nster
25
3-Amino-chromanes and Tetrahydroquinolines as Selective 5-HTEBI
University of Minnesota Twin Cities
17
Discovery of new potent dual sigma receptor/GluN2b ligands with antioxidant property as neuroprotective agents.EBI
University of Trieste
6
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.EBI
Qbi Covid-19 Research Group (Qcrg)
9
Pyridine bioisosteres of potent GluN2B subunit containing NMDA receptor antagonists with benzo[7]annulene scaffold.EBI
Institut F£R Pharmazeutische Und Medizinische Chemie Der Westf£Lischen Wilhelms-Universit£T M£Nster
37
Neurogenic and neuroprotective donepezil-flavonoid hybrids with sigma-1 affinity and inhibition of key enzymes in Alzheimer's disease.EBI
IQM-CSIC
27
Identification of dual Sigma1 receptor modulators/acetylcholinesterase inhibitors with antioxidant and neurotrophic properties, as neuroprotective agents.EBI
University of Pavia
15
New piperidine-based derivatives as sigma receptor ligands. Synthesis and pharmacological evaluation.EBI
University of Trieste
10
Hydroxymethyl bioisosteres of phenolic GluN2B-selective NMDA receptor antagonists: Design, synthesis and pharmacological evaluation.EBI
Institut F£R Pharmazeutische Und Medizinische Chemie Der Universit£T M£Nster
9
Multifunctional thiosemicarbazones and deconstructed analogues as a strategy to study the involvement of metal chelation, Sigma-2 (σEBI
University of Bari Aldo Moro
33
Quest for Novel Chemical Entities through Incorporation of Silicon in Drug Scaffolds.EBI
Csir-National Chemical Laboratory
5
Synthesis of 3-aza[4.4.3]propellanes with high σEBI
Institut F£R Pharmazeutische Und Medizinische Chemie Der Westf£Lischen Wilhelms-Universit£T M£Nster
11
Indole in the target-based design of anticancer agents: A versatile scaffold with diverse mechanisms.EBI
Mazandaran University of Medical Sciences
25
Deconstruction - reconstruction approach to analyze the essential structural elements of tetrahydro-3-benzazepine-based antagonists of GluN2B subunit containing NMDA receptors.EBI
Institut F£R Pharmazeutische Und Medizinische Chemie Der Westf£Lischen Wilhelms-Universit£T M£Nster
44
Structure-Guided Modification of Heterocyclic Antagonists of the P2YEBI
National Institute of Diabetes and Digestive and Kidney Diseases
9
2-Methyltetrahydro-3-benzazepin-1-ols - The missing link in SAR of GluN2B selective NMDA receptor antagonists.EBI
Institut F£R Pharmazeutische Und Medizinische Chemie Der Westf£Lischen Wilhelms-Universit£T M£Nster
42
Synthesis, Receptor Affinity, and Antiallodynic Activity of Spirocyclic σ Receptor Ligands with Exocyclic Amino Moiety.EBI
Universit£T M£Nster
24
Investigating isoindoline, tetrahydroisoquinoline, and tetrahydrobenzazepine scaffolds for their sigma receptor binding properties.EBI
University of Texas At Austin
25
Synthesis and pharmacological evaluation of 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives as sigma-2 receptor ligands.EBI
Guangdong Medical University
6
Contilisant, a Tetratarget Small Molecule for Alzheimer's Disease Therapy Combining Cholinesterase, Monoamine Oxidase Inhibition, and H3R Antagonism with S1R Agonism Profile.EBI
Iqog, Csic
37
Synthesis and pharmacological evaluation of benzamide derivatives as potent and selective sigma-1 protein ligands.EBI
Universities of Lille
46
Chiral-pool synthesis of 1,2,4-trisubstituted 1,4-diazepanes as novelσEBI
Institut F£R Pharmazeutische Und Medizinische Chemie Der Universit£T M£Nster
6
Do spiroindolines have the potential to replace vesamicol as lead compound for the development of radioligands targeting the vesicular acetylcholine transporter?EBI
Helmholtz-Zentrum Dresden-Rossendorf
25
Return of DEBI
University of Nebraska Medical Center
7
Synthesis of conformationally restricted 1,3-dioxanes to analyze the bioactive conformation of 1,3-dioxane-basedσEBI
Institut F£R Pharmazeutische Und Medizinische Chemie Der Westf£Lischen Wilhelms-Universit£T M£Nster
17
Lipase-catalyzed kinetic resolution as key step in the synthesis of enantiomerically pureσ ligands with 2-benzopyran structure.EBI
Universit£T M£Nster
9
Novel Sigma Receptor Ligand-Nitric Oxide Photodonors: Molecular Hybrids for Double-Targeted Antiproliferative Effect.EBI
University of Catania
7
Reevaluation of fenpropimorph as aσ receptor ligand: Structure-affinity relationship studies at humanσEBI
Virginia Commonwealth University
128
SPIROCYCLIC MODULATORS OF CHOLESTEROL BIOSYNTHESIS AND THEIR USE FOR PROMOTING REMYELINATIONBDB
Genentech
60
A CLASS OF FUSED RING COMPOUNDS, AND PREPARATION AND USE THEREOFBDB
Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang)
51
PLASMA KALLIKREIN INHIBITORSBDB
Merck Sharp & Dohme
413
Acylsulfamide Compound and Pharmaceutical Use ThereforBDB
Japan Tobacco
31
N-AROMATIC AMIDE COMPOUNDS, PREPARATION METHODS AND USES THEREOFBDB
Shenzhen Edk Pharmaceutical Technology
96
Imidazopyrimidines and triazolopyrimidines as A2A / A2B inhibitorsBDB
Incyte
1026
Substituted pyrazolo[1,5-a]pyrimidines as TYK2 inhibitorsBDB
Nimbus Lakshmi
119
3,4-disubstituted 3-cyclobutene-1,2-diones and use thereofBDB
Allergan
329
ArylquinazolinesBDB
Merck Patent
6
 
An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19BDB
Pfizer
15
Selective NR2B antagonistsBDB
Bristol Myers Squibb
72
Indole derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2BDB
Merck Sharp & Dohme
32
Benzothiazole compounds and uses thereofBDB
Incyte
70
Use of physiological cooling active ingredients, and agents containing such active ingredientsBDB
Symrise
24
Selective histone deactylase 6 inhibitorsBDB
H. Lee Moffitt Cancer Center and Research Institute
2
Oxazetidine derivatives, process for preparing them and use in human medicine and in cosmeticsBDB
Galderma Research & Development
3
Optimization of a direct spectrophotometric method to investigate the kinetics and inhibition of sialidases.BDB
Universit�� Degli Studi Di Siena
47
Highly Potent Cell-Permeable and Impermeable NanoLuc Luciferase Inhibitors.BDB
Promega Biosciences
195
Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseasesBDB
Merck Sharp & Dohme
100
Inhibition of WDR5 interaction with its binding partnersBDB
University of Michigan
90
N2,N4-bis(4-(piperazine-1-yl)phenyl)pirimidine-2,4-diamine derivative or pharmaceutically acceptable salt thereof, and composition containing same as active ingredient for preventing or treating cancerBDB
Korea Research Institute of Chemical Technology